Drugs / Prazocin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04320589 Comparator | Jun 2019 → Aug 2021 | pheochromocytoma | National Cancer Institute, Egypt | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prazocin | “Prazocin (minipress): 0.5-20 mg/day” NCT04320589 ↗ |
| Known as | minipress | “Prazosin (minipress): 0.5-20 mg/day” NCT04320589 ↗ |